ReproCELL Incorporated Logo

ReproCELL Incorporated

Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.

4978 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ReproCELL Incorporated is a global life sciences company providing products and services for preclinical and clinical research, with a focus on stem cell technology, drug discovery, and regenerative medicine. Established in 2003 as a pioneer in the field, the company offers a comprehensive portfolio that supports the entire research workflow. Key offerings include induced pluripotent stem cell (iPSC)-derived human cells, such as neurons and cardiomyocytes, clinical gene editing services, cell culture reagents, and end-to-end discovery platforms for neuroscience and immuno-oncology. ReproCELL serves scientists and pharmaceutical companies worldwide, aiming to accelerate the translation of research into novel therapies and improve human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-26 02:41
Regulatory News Service
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese 23.4 KB
2025-06-26 02:41
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-26 02:40
Annual Report
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-13 07:31
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-13 07:31
Interim Report
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese 221.1 KB
2024-06-26 03:02
Post-Annual General Meeting Information
臨時報告書
Japanese 28.0 KB
2024-06-25 07:31
Governance Information
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese 22.2 KB
2024-06-25 07:30
Registration Form
確認書
Japanese 8.2 KB
2024-06-25 07:29
Annual Report
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-05-23 08:02
Regulatory News Service
臨時報告書
Japanese 20.0 KB
2024-02-09 07:24
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-02-09 07:23
Quarterly Report
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese 227.6 KB
2023-11-10 07:05
Quarterly Report
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese 213.2 KB
2023-11-10 07:03
Regulatory News Service
確認書
Japanese 8.1 KB
2023-08-10 08:03
Report Publication Announcement
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.